FDA Approved: KIRKLAND SIGNATURE ALLERCLEAR D 24 HR EXTENDED RELEASE — Supplemental Application (Kirkland-COSTCO WHOLESALE COMPANY)

View source ↗

Summary

FDA granted supplemental approval for Kirkland Signature Allerclear D 24 HR Extended Release, a loratadine and pseudoephedrine sulfate combination product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• KIRKLAND SIGNATURE ALLERCLEAR D 24 HR EXTENDED RELEASE (Loratadine and Pseudoephedrine Sulfate)

Snippet

SUPPL AP for KIRKLAND SIGNATURE ALLERCLEAR D 24 HR EXTENDED RELEASE (LORATADINE AND PSEUDOEPHEDRINE SULFATE)